Healthcare provider profile · identity verified

Josephine Ellis, MD

Family Practice · ROCHESTER, NY · NPI 1225186901

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	337	104
Atorvastatin Calcium	Atorvastatin Calcium	284	98
Rosuvastatin Calcium	Rosuvastatin Calcium	249	84
Losartan Potassium	Losartan Potassium	168	49
Lisinopril	Lisinopril	163	52
Amlodipine Besylate	Amlodipine Besylate	159	52
Famotidine	Famotidine	150	42
Metformin Hcl	Metformin Hcl	120	39
Sertraline Hcl	Sertraline Hcl	117	36
Gabapentin	Gabapentin	112	32
Omeprazole	Omeprazole	97	36
Hydrochlorothiazide	Hydrochlorothiazide	95	28
Albuterol Sulfate Hfa	Albuterol Sulfate	92	34
Fluticasone Propionate	Fluticasone Propionate	82	25
Pantoprazole Sodium	Pantoprazole Sodium	79	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	17
Bupropion Xl	Bupropion Hcl	63	19
Simvastatin	Simvastatin	63	21
Alprazolam	Alprazolam	61	27
Escitalopram Oxalate	Escitalopram Oxalate	61	17
Duloxetine Hcl	Duloxetine Hcl	59	16
Metformin Hcl Er	Metformin Hcl	56	18
Tramadol Hcl	Tramadol Hcl	50	17
Metoprolol Succinate	Metoprolol Succinate	49	18
Trazodone Hcl	Trazodone Hcl	49	17
Hydroxyzine Hcl	Hydroxyzine Hcl	46	18
Fluoxetine Hcl	Fluoxetine Hcl	45	14
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Irbesartan	Irbesartan	42	16
Nifedipine Er	Nifedipine	42	11
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	39	39
Clonazepam	Clonazepam	38	11
Glipizide Er	Glipizide	38	suppressed
Atenolol	Atenolol	37	15
Lorazepam	Lorazepam	35	12
Mirtazapine	Mirtazapine	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	11
Zolpidem Tartrate	Zolpidem Tartrate	31	11
Mometasone Furoate	Mometasone Furoate	30	15
Eliquis	Apixaban	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Meloxicam	Meloxicam	29	15
Buspirone Hcl	Buspirone Hcl	28	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	11
Furosemide	Furosemide	26	16
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Nystatin	Nystatin	23	11
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Temazepam	Temazepam	21	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Methylprednisolone	Methylprednisolone	19	18
Pregabalin	Pregabalin	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Baclofen	Baclofen	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	17	suppressed
Fentanyl	Fentanyl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Torsemide	Torsemide	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	12
Acyclovir	Acyclovir	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Prednisone	Prednisone	15	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Famciclovir	Famciclovir	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Isibloom	Desogestrel-Ethinyl Estradiol	12	suppressed
Naproxen	Naproxen	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Diazepam	Diazepam	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Metronidazole	Metronidazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error